Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01334866 · ClinicalTrials.gov registry record · Phase 4
Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery
A Phase 4 study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- Phase 4
- Development phase
- 91
- Enrollment target
NCT01334866 is a Phase 4 study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 91 participants.
The verdict
NCT01334866, a Phase 4 study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 91 participants
- Enrollment target
Study Summary
This clinical study has been developed to evaluate the clinical outcomes in patients undergoing coronary artery bypass grafting via Minimally Invasive Coronary Surgery (MICS); a minimally invasive coronary bypass procedure that is done on a beating heart via a smaller chest incision, thus avoiding the invasiveness of the standard procedure.
Interventions
- PROCEDURE Minimally invasive coronary artery bypass graft surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01334866
The ClinicalTrials.gov registry entry for NCT01334866 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minimally invasive coronary artery bypass graft surgery is the first listed.
NCT01334866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01334866 about?
NCT01334866 is a clinical study titled "Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery". This clinical study has been developed to evaluate the clinical outcomes in patients undergoing coronary artery bypass grafting via Minimally Invasive Coronary Surgery (MICS); a minimally invasive coronary bypass procedure that is done on a beating heart via a smaller chest incision, thus avoiding t...
What is the current status of trial NCT01334866?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 91 participants. The study started on 2009-12. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01334866?
The interventions under investigation include: Minimally invasive coronary artery bypass graft surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01334866?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.